Back to All Events

Vaccines and Related Biological Products Advisory Committee ([VRBPAC])

  • IQVIA Solutions Denmark A/S Denmark (map)

The USFDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Tuesday February 28, 2023. The committee will meet in open session to discuss and make recommendations on the safety and effectiveness of ABRYSVO (Respiratory Syncytial Virus Vaccine), submitted by Pfizer, with a requested indication, in Biologics License Application (BLA) 125769 (STN 125769/0), for active immunization for the prevention of acute respiratory disease and lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-february-28-march-1-2023-meeting#event-materials
Earlier Event: February 15
Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee ([AADPAC]) and the Nonprescription Drugs Advisory Committee (NDAC)
Later Event: March 1
Vaccines and Related Biological Products Advisory Committee [(VRBPAC)]